<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:admin="http://webns.net/mvcb/"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

<channel>
<title>Corante New York</title>
<link>http://newyork.corante.com/</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:creator>basulto@gmail.com</dc:creator>
<dc:date>2005-10-26T22:29:57-05:00</dc:date>
<admin:generatorAgent rdf:resource="http://www.movabletype.org/?v=3.2" />
<sy:updatePeriod>hourly</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>
<sy:updateBase>2000-01-01T12:00+00:00</sy:updateBase>

<item>
<title>An innovative medical devices company on Long Island</title>
<link>http://newyork.corante.com/archives/2005/10/26/an_innovative_medical_devices_company_on_long_island.php</link>
<description>A big hat tip to Optimyst Systems of West Islip: the Long Island-based company was the winner in the &quot;Medical Devices&quot; category of the Wall Street Journal&apos;s Technology Innovation Awards 2005. The company won the award for a new device...</description>
<guid isPermaLink="false">51275@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-10-26T22:29:57-05:00</dc:date>
</item>
<item>
<title>Invasion of the Brooklyn Body Snatchers</title>
<link>http://newyork.corante.com/archives/2005/10/10/invasion_of_the_brooklyn_body_snatchers.php</link>
<description> Just in time for Halloween: since Friday, the New York Daily News has been keeping constant tabs on some ghoulish goings-on at cemeteries and funeral homes around the city. Concerned that a team of &quot;body snatchers&quot; has been carving...</description>
<guid isPermaLink="false">51227@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-10-10T06:12:23-05:00</dc:date>
</item>
<item>
<title>$86 million IPO for Westchester biotech firm</title>
<link>http://newyork.corante.com/archives/2005/10/07/86_million_ipo_for_westchester_biotech_firm.php</link>
<description>Acorda Therapeutics, a commercial-stage biopharmaceutical firm that develops products to treat disorders of the central nervous system (i.e. multiple sclerosis and spinal cord injury), has filed with the SEC for an $86 million IPO. The Hawthorne, New York-based company&apos;s one...</description>
<guid isPermaLink="false">51221@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-10-07T06:53:50-05:00</dc:date>
</item>
<item>
<title>A Chinese company that&apos;s full of... biofertilizer</title>
<link>http://newyork.corante.com/archives/2005/09/29/a_chinese_company_thats_full_of_biofertilizer.php</link>
<description>AXcess News reports that executives from Bodisen Biotech, &quot;the first bio fertilizer company from China ever to be listed on an American stock exchange,&quot; rang the opening bell at the American Stock Exchange on Wednesday. Bodisen became an AMEX listed...</description>
<guid isPermaLink="false">51188@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-09-29T06:54:56-05:00</dc:date>
</item>
<item>
<title>Animal rights activists take on the New York Stock Exchange -- and win</title>
<link>http://newyork.corante.com/archives/2005/09/10/animal_rights_activists_take_on_the_new_york_stock_exchange_and_win.php</link>
<description>Apparently, a New Jersey-based life sciences firm ran into quite a bit of trouble from animal rights activists on the day of its IPO last week. According to the Wall Street Journal print edition, the NYSE announced that the company&apos;s...</description>
<guid isPermaLink="false">51123@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-09-10T06:43:12-05:00</dc:date>
</item>
<item>
<title>Can New York really become a biotech powerhouse?</title>
<link>http://newyork.corante.com/archives/2005/08/24/can_new_york_really_become_a_biotech_powerhouse.php</link>
<description> On page 10 of today&apos;s Metro newspaper, I&apos;ve written an op-ed piece on New York&apos;s biotech sector: &quot;Can we really become a biotech powerhouse?&quot; About two weeks ago, the city announced plans to create a sprawling, $700 million biotech...</description>
<guid isPermaLink="false">51040@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-08-24T07:15:57-05:00</dc:date>
</item>
<item>
<title>Look to the East River for the future of New York&apos;s biotech industry</title>
<link>http://newyork.corante.com/archives/2005/08/11/look_to_the_east_river_for_the_future_of_new_yorks_biotech_industry.php</link>
<description> In a deal announced yesterday by Mayor Bloomberg, a California real estate company will pump $700 million into the creation of the East River Science Park on the campus of Bellevue Hospital Center. It&apos;s all part of an effort...</description>
<guid isPermaLink="false">50985@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-08-11T08:13:55-05:00</dc:date>
</item>
<item>
<title>On Long Island, researchers bring back the polio pathogen</title>
<link>http://newyork.corante.com/archives/2005/07/29/on_long_island_researchers_bring_back_the_polio_pathogen.php</link>
<description>A scary item in Newsweek: at a time when &quot;health officials have been scrambling to stamp out polio around the world,&quot; a virologist at Stony Brook University has successfully assembled a polio pathogen from scratch. Why? Oh, come on, that&apos;s...</description>
<guid isPermaLink="false">50959@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-07-29T11:20:17-05:00</dc:date>
</item>
<item>
<title>In Brooklyn, a stem cell research controversy</title>
<link>http://newyork.corante.com/archives/2005/07/15/in_brooklyn_a_stem_cell_research_controversy.php</link>
<description>Anyone passing by the Brighton Beach/Coney Island area this weekend should pick up a copy of Bay News, a local Brooklyn publication that has some great coverage of issues affecting local residents. The cover story is almost impossible to miss:...</description>
<guid isPermaLink="false">50895@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-07-15T16:28:26-05:00</dc:date>
</item>
<item>
<title>Canadian regulators approve lung cancer drug Tarceva</title>
<link>http://newyork.corante.com/archives/2005/07/15/canadian_regulators_approve_lung_cancer_drug_tarceva.php</link>
<description>Good news for Long Island-based OSI Pharmaceuticals, with Canadian regulators giving their approval for Tarceva, the company&amp;#146;s lung-cancer drug. Tarceva, which OSI developed in partnership with Genentech, was approved in the United States last November, and is expected to be...</description>
<guid isPermaLink="false">50889@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-07-15T06:52:36-05:00</dc:date>
</item>
<item>
<title>New Yorkers turn their backs on stem cell research</title>
<link>http://newyork.corante.com/archives/2005/07/08/new_yorkers_turn_their_backs_on_stem_cell_research.php</link>
<description>Newsday reports that support for stem cell research in New York lags behind the national average. While approximately 45% of New Yorkers polled by Cornell University&apos;s Survey Research Institute said they would support stem-cell research and would approve establishment of...</description>
<guid isPermaLink="false">50856@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-07-08T07:20:37-05:00</dc:date>
</item>
<item>
<title>Pharmaceutical companies reconsider the future of blockbuster drugs</title>
<link>http://newyork.corante.com/archives/2005/07/05/pharmaceutical_companies_reconsider_the_future_of_blockbuster_drugs.php</link>
<description>In the New York Times, Alex Berenson writes that blockbuster drugs are &quot;so last century.&quot; Drug companies are starting to come to the realization that they do an &quot;awful job of finding new medicines.&quot; Not only that -- &quot;they rely...</description>
<guid isPermaLink="false">50837@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-07-05T06:25:58-05:00</dc:date>
</item>
<item>
<title>Pfizer goes 0-2 with new drugs in development</title>
<link>http://newyork.corante.com/archives/2005/07/01/pfizer_goes_02_with_new_drugs_in_development.php</link>
<description>If you&apos;re going to release bad news, do it when nobody&apos;s watching. That&apos;s what Pfizer must be thinking by releasing news that it is halting development of two promising drugs (one for HIV, one for smoker&apos;s lung and asthma) on...</description>
<guid isPermaLink="false">50832@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-07-01T11:08:56-05:00</dc:date>
</item>
<item>
<title>NYC ranks #4 among biotech hubs</title>
<link>http://newyork.corante.com/archives/2005/06/22/nyc_ranks_4_among_biotech_hubs.php</link>
<description>At the BIO 2005 conference, the Milken Institute released a study that ranked Boston, San Francisco, Philadelphia and New York as the top four biotech hubs in the country. For both Philly and New York, the Milken Institute noted the...</description>
<guid isPermaLink="false">50787@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-06-22T07:33:46-05:00</dc:date>
</item>
<item>
<title>Leon Black&apos;s new stem cell institute</title>
<link>http://newyork.corante.com/archives/2005/06/13/leon_blacks_new_stem_cell_institute.php</link>
<description>The American Council on Science and Health points to an article in the Wall Street Journal about financier Leon Black&apos;s $10 million gift to the Mount Sinai School of Medicine. The funds will be used for the creation of the...</description>
<guid isPermaLink="false">50737@http://newyork.corante.com/</guid>
<dc:subject>Biotech</dc:subject>
<dc:date>2005-06-13T07:00:42-05:00</dc:date>
</item>


</channel>
</rss>